Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why GLUE? Monte Rosa Therapeutics, Inc. Analysis, Price & AI Insights | Whystock

GLUE

$18.80-0.35 (-1.83%)

Market ClosedLast close May 1

Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.